Stats
Mind
“Choose correct statistical methods and avoid analysis catastrophes.”
The Vision
The Vision
“Statistical methodology is the mathematical arbiter of scientific truth; it converts raw clinical observations into verifiable evidence that can guide practice and policy. Without rigorous statistical discipline, a trial ceases to measure biology and instead measures the noise of human error, measurement variability, and analytical flexibility. Stats Mind provides a high-fidelity framework to eliminate 'p-hacking,' analytical opportunism, and post-hoc justification, ensuring that findings are genuine discoveries rather than statistical inventions. In the hierarchy of evidence, the integrity of the analysis is the prerequisite for clinical legitimacy, regulatory acceptance, and reproducibility. When rigor is sacred, medicine advances with trust, transparency, accountability, and human dignity.”
Systemic Failure Audit
Systemic Failure Audit
Status
Active Critical Scanning
Using wrong statistical methods is the #1 technical reason for manuscript rejection, post-publication correction, and retraction across biomedical journals.
48% of published medical papers contain at least one substantive statistical error, often rendering results uninterpretable or misleading for clinicians and policymakers.
38% of manuscripts face desk rejection specifically due to inappropriate statistical methods, incorrect model choice, or misapplied tests.
An estimated $18.9 billion is wasted annually on trials that use incorrect statistical methods, producing unreliable findings that cannot be translated into practice.
Retraction risk: Using parametric tests on severely skewed data (e.g., costs, biomarkers, length of stay) can inflate effect sizes and trigger post-publication failures.
Lost credibility: Reviewers who detect 'p-hacking' (testing many outcomes but reporting only p<0.05) frequently blacklist investigators from future favorable review.
Grant denial: NIH and ICMR reviewers routinely reject proposals that use incorrect sample size formulas, lack power justification, or omit a missing data plan.
The Disaster Case
The Disaster Case
“Dr. Stella Numbers spent 4.7 years on an NIH-funded RCT comparing Mediterranean vs. Low-Fat diets, only to have the work retracted due to basic statistical errors.”
The Deadly Sins
The Deadly Sins
Detection & Mitigation ProtocolMultiple Comparisons Without Adjustment
"Testing many outcomes increases the chance of seeing a 'significant' result by luck alone. 20 tests carry a 64% false-positive risk if unadjusted."
Mandate formal multiplicity corrections (e.g., Bonferroni, Benjamini-Hochberg) for all secondary comparisons.
Parametric Tests on Non-Normal Data
"Using t-tests or ANOVA on skewed data (e.g., biomarkers, costs, length of stay) inflates false positives by 10-30% and distorts confidence intervals."
Perform Shapiro-Wilk tests; if p<0.05, switch to non-parametric tests like Mann-Whitney U or apply log-transformations.
Treating Repeated Measures as Independent
"Measuring the same patient multiple times and using separate t-tests ignores within-subject correlation and invalidates p-values and standard errors."
Use Mixed-Effects Models or Repeated-Measures ANOVA to account for the nested structure of longitudinal data.
No Statistical Analysis Plan (SAP)
"Allows 'Hypothesis Shifting' after seeing results, a form of p-hacking that destroys scientific integrity and regulatory credibility."
Register a timestamped SAP on Clinical Trials.gov or OSF before database lock and unblinding.
Reporting p-values Without Effect Sizes
"Fails to distinguish between mathematical significance and clinical importance (MCID), misleading clinicians."
Always report 95% Confidence Intervals and Cohen's d or odds ratios to quantify the magnitude of the clinical effect.
Ignoring Missing Data
"High dropout rates (>30%) without multiple imputation lead to severe selection bias and overestimation of treatment effects."
Implement Multiple Imputation by Chained Equations (MICE) or Full Information Maximum Likelihood (FIML) for missingness >5%.
Underpowered Sample Sizes
"62% of trials are underpowered, making them 'futile' because they cannot detect real treatment effects even if they exist."
Conduct formal a priori power analysis using realistic SD estimates and target 80-90% power for the primary outcome.
Technical Standards
Technical Standards
- Report absolute numbers and percentages for binary data.
- Report mean ± SD, mean difference, and 95% CI for continuous data.
- Always compare findings to the minimal clinically important difference (MCID).
Readiness Checklist
Readiness Checklist
Decision Architecture
Decision Architecture
Implementation Playbook
Implementation Playbook
phase 1 design
Define primary outcome, timepoint, and estimand before any data collection. Specify exact statistical model (e.g., mixed model, Cox, logistic). Predefine covariates with clinical justification.
phase 2 sap lock
Register SAP on Clinical Trials.gov or OSF. Obtain PI and Statistician signatures. Freeze all analytic decisions before unblinding.
phase 3 data quality
Run range and logic checks before analysis. Assess missing data patterns (MCAR/MAR/MNAR). Predefine imputation strategy if needed.
phase 4 masked analysis
Analyst works with Group A vs Group B labels only. Code finalized before unblinding. Independent statistician peer-reviews code.
phase 5 unblinding execution
Unblind only after analysis code is locked. Run final analysis exactly as pre-specified. Document any deviations with justification.
phase 6 reporting
Report effect sizes, 95% CIs, and MCID comparison. Clearly label exploratory analyses. Publish SAP alongside manuscript.
phase 7 reproducibility
Archive analysis code, data dictionary, and logs. Enable independent replication where possible. Maintain transparent documentation for audits.
Foundational Methodology
Foundational Methodology
Canonical Foundations
Canonical Foundations
Authority & Lineage Audit"Altman — Practical Statistics for Medical Research"
"Gelman et al. — Bayesian Data Analysis"
"Harrell — Regression Modeling Strategies"
"Hernán & Robins — Causal Inference: What If"
"Moher et al. — CONSORT 2010 and Extensions"
"Little & Rubin — Statistical Analysis with Missing Data"
"Rubin — Multiple Imputation for Nonresponse in Surveys"
"Cochrane Handbook for Systematic Reviews of Interventions"
"Senn — Statistical Issues in Drug Development"
"Ioannidis — Why Most Published Research Findings Are False"
The Final Truth
The Final Truth
“The statistical analysis is the moral and scientific audit trail of a study. When rigor is sacred, medicine advances with legitimacy, and every p-value represents a genuine step toward the truth.”